May 14, 2012
According to the consolidated settlement of accounts for the fiscal year ended March 2012 announced on May 10 by Dainippon Sumitomo Pharma (DSP), its sales and net profits declined 7.7% and 48.6%, respectively, compared to the previous fiscal year, to...read more